OGN

Organon & Co. (OGN) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-08-01

Environmental

OGN’s R&D intensity is modest at 5.8% of revenue, suggesting a smaller innovation footprint than research-heavy healthcare peers that often sustain higher pipeline investment.

The company’s capital allocation appears less environmentally differentiated than peers with larger R&D budgets, limiting evidence of ESG-linked product or process innovation.

No direct emissions, energy, or waste disclosures were provided, so relative environmental positioning remains constrained versus peers with more transparent operational sustainability reporting.

As a healthcare company, OGN’s environmental profile is typically less resource-intensive than manufacturing-heavy peers, but the available metrics do not show a clear leadership advantage.

Social

OGN’s low stock-based compensation at 0.5% of revenue indicates restrained equity dilution, which can support employee alignment versus peers with heavier compensation-driven dilution.

The absence of provided workforce, safety, or access metrics limits evidence of stronger social performance relative to peers that disclose broader human-capital indicators.

Healthcare peers often face elevated patient-access and product-responsibility expectations, and the available data do not show OGN materially outperforming on those social dimensions.

Without controversy or incident data, OGN appears broadly in line with peers, but the disclosure set is too narrow to justify a stronger social ranking.

Governance

OGN’s debt-to-equity ratio of 8.5x signals a highly leveraged capital structure, which is materially weaker than peers with more conservative balance sheets and governance flexibility.

Net debt to EBITDA of 5.7x suggests limited financial resilience, increasing governance sensitivity around capital allocation and covenant management versus less levered peers.

Low stock-based compensation supports some discipline in executive pay design, but it does not offset the governance risk implied by elevated leverage.

The available metrics do not show major board or control failures, yet the balance-sheet profile remains a relative governance कमजोरी versus stronger peers.

Overall Score

OGN’s ESG positioning is mixed versus peers, with restrained compensation discipline offset by limited disclosure breadth and a materially leveraged capital structure.

Score Driver: High Leverage Is The Decisive Relative Weakness, Because It Elevates Governance Risk And Constrains Flexibility Versus Peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Organon & Co.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →